NEURONETICS, INC.
STIMCIK 0001227636
Revenue (TTM)
$141.83M
+99.2% YoY
Q1 May 2026
Net Income (TTM)
−$42.63M
+10.8% YoY
Q1 May 2026
EPS Diluted (TTM)
−$0.65
+57.2% YoY
Q1 May 2026
Gross Margin
47.1%
Q1 May 2026
Operating Margin
-25.0%
Q1 May 2026
Net Margin
-30.1%
Q1 May 2026
Free Cash Flow (TTM)
—
Q1 May 2026
Cash
$13.21M
Q1 May 2026
Total Debt
$72.72M
Q1 May 2026
Shares Outstanding
69.59M sh
Q1 May 2026